NCT02158364View on ClinicalTrials.gov

Freeze-dried Live Attenuated Measles/Rubella Combined Vaccine (Schwarz FF-8 Strain/TO-336 Strain) Specified Drug-use Survey of Vaccinees After the Second Vaccination

CompletedOBSERVATIONAL
Enrollment

3,331

Participants

Timeline

Start Date

March 28, 2007

Primary Completion Date

February 20, 2011

Study Completion Date

February 20, 2011

Conditions
Measles/Rubella
Interventions
DRUG

Freeze-dried live attenuated measles and rubella combined vaccine (Schwarz FF-8 strain/TO-336 strain)

Freeze-dried live attenuated measles and rubella combined vaccine (Schwarz FF-8 strain/TO-336 strain)

Trial Locations (1)

Unknown

Osaka

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT02158364 - Freeze-dried Live Attenuated Measles/Rubella Combined Vaccine (Schwarz FF-8 Strain/TO-336 Strain) Specified Drug-use Survey of Vaccinees After the Second Vaccination | Biotech Hunter | Biotech Hunter